International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-3 doi: 10.5281/zenodo.15868327
Original Article
Stiff-Person Syndrome: A Rarity
 ,
Published
June 30, 2025
Abstract
  1. Aim: To report a case of stiff-person syndrome presented with paraparesis, musclespasm and newly diagnosed case of Diabetes Mellitus.

 

  1. Methods and result: A 27 years old female presented to us with complaints of progressive difficulty in walking with intermittent muscle spasm. It was in the form of extensor posturing. Patient also had past history of Diabetes Mellitus. On evaluation patient found to have Stiff-Person Syndrome on the basis of clinical examination, electrophysiology and positive anti GAD-65 antibody. Our patient responded well to IvIG and Inj. Methylprednisolone with symptomatic therapy with diazepam and baclofen.

 

  1. Conclusion: Here we reviewed the case presentation, diagnostic and therapeutic options for this severe disabling disease. Our case shows treatment strategies for Stiff Person Syndrome on the basis of evidence based studies. As large evidence based studies for treatment of SPS is still lacking, So further observation and large case series will be of use in future.
Recommended Articles
Loading Image...
Volume-6, Issue-3
Citations
391 Views
263 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved